Unknown

Dataset Information

0

Generation and Characterization of a Spike Glycoprotein Domain A-Specific Neutralizing Single-Chain Variable Fragment against Porcine Epidemic Diarrhea Virus.


ABSTRACT: The emergence of the genotype (G) 2 and re-emergence of the G1 porcine epidemic diarrhea virus (PEDV) has caused severe economic impacts in the past decade. Developments of efficient vaccines against new variants of PEDV have been challenging, not least because of the difficulties in eliciting mucosal and lactogenic immunity. A single-chain fragment variable (scFv) capable of efficient antigen recognition is an alternative to vaccination and treatment of a viral infection. In the present study, the variable regions of the light chain and the heavy chain of a G2b PEDV spike domain A (S1A)-specific neutralizing monoclonal antibody (mAb) were sequenced, constructed with a (G4S) x3 linker, and produced by a mammalian protein expression system. Our results demonstrated that the PEDV S1A domain scFv was able to bind to S proteins of both G1 and G2b PEDVs. Nevertheless, the scFv was only capable of neutralizing the homologous G2b PEDV but not the G1 PEDV. The binding ability of the G2b-specific neutralizing scFv was not able to predict the neutralizing ability toward heterologous PEDV. The anti-PEDV S1A scFv presented herein serves as a potential therapeutic candidate against the virulent G2b PEDV.

SUBMITTER: Chang CY 

PROVIDER: S-EPMC8402611 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Generation and Characterization of a Spike Glycoprotein Domain A-Specific Neutralizing Single-Chain Variable Fragment against Porcine Epidemic Diarrhea Virus.

Chang Chia-Yu CY   Wang Yong-Sheng YS   Wu Jou-Fei JF   Yang Tzu-Jing TJ   Chang Yen-Chen YC   Chae Chanhee C   Chang Hui-Wen HW   Hsu Shang-Te Danny SD  

Vaccines 20210729 8


The emergence of the genotype (G) 2 and re-emergence of the G1 porcine epidemic diarrhea virus (PEDV) has caused severe economic impacts in the past decade. Developments of efficient vaccines against new variants of PEDV have been challenging, not least because of the difficulties in eliciting mucosal and lactogenic immunity. A single-chain fragment variable (scFv) capable of efficient antigen recognition is an alternative to vaccination and treatment of a viral infection. In the present study,  ...[more]

Similar Datasets

| S-EPMC6356844 | biostudies-literature
| S-EPMC8205199 | biostudies-literature
| S-EPMC7111671 | biostudies-literature
| S-EPMC8755980 | biostudies-literature
| S-EPMC7112428 | biostudies-literature
| S-EPMC7212245 | biostudies-literature
| S-EPMC5446644 | biostudies-literature
| S-EPMC8807655 | biostudies-literature
| S-EPMC8139691 | biostudies-literature
| S-EPMC7088867 | biostudies-literature